Structure-Guided Discovery of Drug-like Compounds Targeting HPV16 E6 for Antiviral Therapy Development.

Our findings provide a robust computational framework for the identification of drug-like small molecules targeting HPV16 E6, offering promising candidates for further development as antiviral agents against HPV-associated diseases. Experimental validation is warranted to confirm the inhibitory activity and therapeutic potential of these compounds.